IS THROMBOPROPHYLAXIS MANDATORY IN THE MANAGEMENT OF PATIENTS WITH ADVANCED CANCER?

Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study

N. Tubiana-Mathieu